APA (7th ed.) Citation

Farrash, W. F., Aslam, A., Almaimani, R., Minshawi, F., Almasmoum, H., Alsaegh, A., . . . Refaat, B. (2023). Metformin and thymoquinone co‐treatment enhance 5‐fluorouracil cytotoxicity by suppressing the PI3K/mTOR/HIF1α pathway and increasing oxidative stress in colon cancer cells. Biofactors, 49(4), 831. https://doi.org/10.1002/biof.1947

Chicago Style (17th ed.) Citation

Farrash, Wesam F., et al. "Metformin and Thymoquinone Co‐treatment Enhance 5‐fluorouracil Cytotoxicity by Suppressing the PI3K/mTOR/HIF1α Pathway and Increasing Oxidative Stress in Colon Cancer Cells." Biofactors 49, no. 4 (2023): 831. https://doi.org/10.1002/biof.1947.

MLA (9th ed.) Citation

Farrash, Wesam F., et al. "Metformin and Thymoquinone Co‐treatment Enhance 5‐fluorouracil Cytotoxicity by Suppressing the PI3K/mTOR/HIF1α Pathway and Increasing Oxidative Stress in Colon Cancer Cells." Biofactors, vol. 49, no. 4, 2023, p. 831, https://doi.org/10.1002/biof.1947.